SCHEMBL28818259

SCHEMBL28818259

CC(C)NC(=O)c1ccc(Cn2cc(C(=O)O)cn2)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 5/20 0.69
▸ KLK1 P06870 1/20 0.69
▸ KDM4E B2RXH2 3/20 0.58
▸ HSD17B10 Q99714 1/20 0.56
▸ ALDH1A1 P00352 4/20 0.54
▸ LMNA P02545 3/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ XDH P47989 1/20 0.48
▸ CYP1A2 P05177 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ MAPT P10636 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL553405 0.85 KLKB1 (0.64) KLKB1KLK1KDM4EALDH1A1LMNA
SCHEMBL1912400 0.83 HSD17B10 (0.77) KLKB1KLK1KDM4EHSD17B10ALDH1A1
SCHEMBL4785951 0.83 HSD17B10 (0.59) KLKB1KLK1KDM4EHSD17B10ALDH1A1
SCHEMBL15875754 0.82 KLKB1 (1.00) KLKB1KLK1KDM4E
SCHEMBL4188538 0.81 HSD17B10 (0.61) KLKB1KLK1KDM4EHSD17B10ALDH1A1
SCHEMBL3548974 0.80 KLKB1 (0.63) KLKB1KLK1KDM4EALDH1A1L3MBTL1
SCHEMBL948453 0.79 HSD17B10 (0.61) KLKB1KDM4EHSD17B10ALDH1A1LMNA
SCHEMBL19299982 0.79 HSD17B10 (0.65) KLKB1KLK1KDM4EHSD17B10ALDH1A1
SCHEMBL4019065 0.79 HSD17B10 (0.57) KLKB1KLK1KDM4EHSD17B10ALDH1A1
SCHEMBL369349 0.79 L3MBTL1 (0.58) KLKB1HSD17B10L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103080104-B N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein NOVARTIS AG 2015-04-08 — — CN disclosed
Send feedback